Contenido automatizado
Parcialmente escrito o traducido con información proporcionada por una herramienta de inteligencia artificial.
prima:Romark pharmaceuticals inoperative, while owner benefits from tax incentives

El Nuevo Día visited the manufacturing facilities where some 200 people are supposed to work to find closed gates, weeds and clear deterioration

August 28, 2024 - 2:25 PM

Archival note
This content was published more than 3 months ago.
Romark, a biopharmaceutical company that claimed to have a new drug on the way to combat the effects of the coronavirus, is the target of multiple lawsuits in state and federal forums for breach of contract and debts of thousands and, in some cases, even millions of dollars. (Carlos Rivera Giusti)

Manatí and Dorado - A padlocked chain keeps closed the gates of the Romark biopharmaceutical company in Manatí, a company that allegedly owes millions of dollars to local companies and banking institutions, according to El Nuevo Día.

Popular en la Comunidad


Ups...

Nuestro sitio no es visible desde este navegador.

Te invitamos a descargar cualquiera de estos navegadores para ver nuestras noticias: